SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-004890
Filing Date
2015-11-09
Accepted
2015-11-09 17:12:06
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tbuff_10q.htm 10-Q 864360
2 CERTIFICATION tbuff_ex311.htm EX-3.1 9768
3 CERTIFICATION tbuff_ex312.htm EX-31.2 9980
4 CERTIFICATION tbuff_ex321.htm EX-32.1 6311
5 CERTIFICATION tbuff_ex322.htm EX-31.2 6216
  Complete submission text file 0001354488-15-004890.txt   4025204

Data Files

Seq Description Document Type Size
6 tbuff-20150930.xml EX-101.INS 685484
7 tbuff-20150930.xsd EX-101.SCH 48816
8 tbuff-20150930_cal.xml EX-101.CAL 63378
9 tbuff-20150930_def.xml EX-101.DEF 105962
10 tbuff-20150930_lab.xml EX-101.LAB 304039
11 tbuff-20150930_pre.xml EX-101.PRE 234775
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 151216636
SIC: 2834 Pharmaceutical Preparations